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Detection of bacteria, fungi, and viruses by a real-time
PCR assay using universal primers and probes from blood
in patients with febrile neutropenia.
Hideto TERANISHI,  Kazunobu OUCHI
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ABSTRACT  Febrile neutropenia is the main treatment-related cause of mortality in cancer 
patients. During June 2012 to April 2013, 76 blood culture samples from patients receiving 
chemotherapy for hematological malignancy and cancer with febrile neutropenia episodes (FNEs) 
were examined for the presence of bacteria and fungi based on 16S rRNA gene and 18S rRNA 
combined with real-time PCR amplification and sequencing. Furthermore, we used a loop-
mediated isothermal amplification (LAMP) assay for the detection of herpes simplex virus type 
1 and 2 (HSV-1,2), varicella zoster virus (VZV), epstein-barr virus (EBV), cytomegalovirus (CMV) 
and human herpes virus type6 and 7 (HHV-6,7), followed by a real-time PCR amplification 
assay. 
　Of these samples, bacteria were identified in 19 of 76 FNEs (25.0%) by a real-time PCR 
assay and in 9 of 76 (11.8%) by blood culture. In 6 blood culture-positive samples, real-time 
PCR assay detected the same type of bacteria. No fungus was detected both real-time PCR 
assay and blood culture. Viruses were identified in 6 of 76 FNE (7.9%). 
　During antibiotic therapy, all samples were negative in blood culture, but a real time PCR 
assay yielded a positive result in 2 cases of 2 (100%). The number of bacteria DNA copy and 
serum CRP titer of patients with FNE did not correlated well.
　We conclude a real-time PCR assay could be given higher microbe’s detection rate, and 
need shorter turnaround time, and smaller blood sample than blood culture. Using a real-time 
PCR assay combined with blood culture improves microbiological documentation in febrile 
neuropenia episodes. doi：10.11482/KMJ-E40（1）1　(Accepted on September 5, 2013)
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INTRODUCTION 
   In patients receiving chemotherapy for treatment 
of cancer, febrile neutropenia episodes (FNEs) 
are one of the most common adverse event by 
chemotherapy. When fever occurs in neutropenia 
patients, they are more likely to develop a serious 
infectious disease with various microbes1-4).
   The definitions of febrile neutropenia (FN) in 
Infectious Disease Society of America (IDSA) 
guidelines are general criteria that should be used 
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to identify patients in whom empirical antibiotic 
therapy must be initiated5). Fever is defined as a 
single oral temperature measurement of ≧ 38.3℃ 
or a temperature of ≧ 38.0℃ sustained over a one-
hour period. Neutropenia is defined as an absolutely 
neutrophilic count (ANC) less than 500 cells/mm3 
or an ANC that is expected to decrease less than 500 
cells/mm3 during the next 48 hours.
   Management of FN is very important, because 
infections of various microbes are major causes 
of morbidity and mortality in patients receiving 
chemotherapy1-4).
   Seventy five percent of FN patients resulted in 
death, before the era of an empirical antibiotic 
therapy introduced2). Recently, the empirical 
antibiotic therapy has been used in all patients 
with FN. We administer antibiotic therapy in 
consideration of causative microorganism predicted 
for FN patients as soon as possible, after we 
undertook blood culture. However, the sensitivity of 
blood culture remains low, and also it takes time to 
identify causative microorganism by blood culture, 
so we cannot give appropriate and specific antibiotic 
therapy quickly for causative microorganisms.
   We set up the microbes detecting system by 
the real-time PCR method that we can detect 
bacteria, fungi, and viruses from a blood sample 
in a short time. Primers targeting the 16S rRNA 
gene for detecting bacteria3,4) and 18S rRNA gene 
for detecting of fungi6-9) were used for the real-
time PCR. Furthermore, we used a loop-mediated 
isothermal amplification (LAMP) assay for 
detecting herpes viruses, such as herpes simplex 
virus type1 and 2 (HSV-1,2), varicella zoster virus 
(VZV), cytomegalovirus (CMV), epstein-barr virus 
(EBV) and human herpes virus type6 and 7 (HHV-
6,7). If the  LAMP assay is positive, we performed a 
real-time PCR assay.
MATERIALS AND METHODS
Patients and blood samples:
   Patients with malignancy presenting fever (axillary 
temperature equal or higher than 38.0℃) and severe 
neutropenia (ANC less than 0.5×109/l) induced by 
chemotherapy were eligible for this study. Multiple 
FNEs per patient were allowed to include this 
study. We took a written informed consent from 
patients or their parents when they were equal or 
less than 15 years old. The study was approved by 
the ethics committee of Kawasaki Medical School. 
We undertook two sets of blood cultures from adult 
patients with FNEs and inoculated 10ml of blood 
each into aerobic bottle and an anaerobic bottle. 
On the other hand, we collected only 3ml of blood 
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Fig. 1.　Nucleic acid amplification tests used in this study for each microbes
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into a pediatric aerobic bottle for child patients. 
Blood culture samples were set in BACTECTMFX 
(Becton, Dickinson and Company, Tokyo, Japan). 
β -D Gulcan was measured in each sample. Blood 
culture samples were also assayed for nucleic acid 
amplification tests as follows (Fig.1).
Bacteria and Fungus protocol
DNA extraction protocol:
   A 400μl of EDTA-anticoagulated peripheral 
blood was used for the real-time PCR assay. Sample 
was stored at -80℃ until DNA extraction. For 
DNA extraction, QIAamp UCP Pathogen Mini kit 
(QIAGEN, Basel, Switzerland) was used under the 
instruction of the manufacture.
A Real-time PCR assay:
   The bacterial primer pairs specific for conserved 
DNA sequences encoding the 16S rRNA gene 
region were used3,4). The real-time PCR reaction 
mixtures were prepared using 10μl of enzyme 
mixture (SsoFast Probes supermix BIO-RAD), 1
μl of 10μM forward primer (AGTTTGATC 
( A / C )  T G G C T C A G ;  S I G M A - A L D R I C H , 
Tokyo, Japan), 1μl of 10μM reverse primer 
(GGACTAC (C/T/A) AGGGTATCTAAT; SIGMA-
ALDRICH, Tokyo, Japan), 0.5μl of 10μM probe 
(CGTATTACCGCGGCTGCTGGCAC; SIGMA-
ALDRICH, Tokyo, Japan) and 5μl of DNA extract 
of the sample. The reaction mixture was made up to 
20μl with water. 
   PCR reactions were performed in the BIO-RAD 
CFX96 Real-Time System (BIOLAD, Tokyo, 
Japan) with preliminary denaturation at 95 ℃ for 1 
minute, followed by 40 amplification cycles (with 
a temperature transition rate of 3.3℃/seconds) of 
deneturation at 95℃ for 5 seconds, annealing at 
53℃ for 10 seconds, and primer extension at 72℃ 
for 20 seconds.   
   The fungal primer pairs specific for conserved 
DNA sequences encoding the 18S rRNA gene 
region were used6-9). Primers bind to conserved 
regions of the fungal 18S rRNA gene and panfungal 
oligonucleotide probes were used to bind to a 
common sequence present in all fungal species. 10
μl of enzyme mixture (SsoFast Probes supermix 
BIO-RAD, Tokyo, Japan), 0.9μl of 10μM forward 
primer (ATT GGA GGG CAA GTC TGG TG; 
SIGMA-ALDRICH, Tokyo, Japan), and 0.9ul of 10
μM (reverse primer CCG ATC CCT AGT CGG 
CAT AG; SIGMA-ALDRICH, Tokyo, Japan), 0.5
μl of 10μM probes (TTC AAC TAC GAG CTT 
TTT AAC TG; SIGMA-ALDRICH, Tokyo, Japan) 
were made up to 20μl with water, as the reaction 
mixture. 
   PCR reactions were performed in the BIO-RAD 
CFX96 Real-Time System (BIOLAD, Tokyo, 
Japan) with preliminary denaturation at 95℃ for 
1minute, followed by 40 amplification cycles (with 
a temperature transition rate of 3.3℃/seconds) of 
deneturation at 95℃ for 5 seconds, annealing and 
primer extention at 60℃ for 30 seconds, with a 
single fluorescence acquisition step at the end of 
extention for the fungal PCR assay.   
Sequencing and phylogenetic identification:
   Bacterial sequence and analyze were used PCR 
products, not real-time PCR products.  
   PCR was performed in a 50μl reaction mixture 
containing 4μl of 0.2mM dNTP mixture, 1μl 
of 10μM forward primer (AGTTTGATC (A/C) 
TGGCTCAG; SIGMA-ALDRICH, Tokyo, Japan), 
1μl of 10μM reverse primer (GGACTAC (C/T/
A) AGGGTATCTAAT; SIGMA-ALDRICH, Tokyo, 
Japan), and 10μl of DNA extract of the sample.
   PCR was carried out in a 2720 Thermal Cycler 
(Applied Biosystems, Foster cuty, CA) with 
preliminary denaturation at 95℃  for 5min, 
followed by 35cycles of amplification consisting of 
denaturation at 94℃, primer annealing at 50℃, and 
elongation at 72℃, each lasting for 30 seconds.  
   Sequencing was performed by ABI 3130xl 
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Genetic Analyzer by BigDye reaction (Applied 
Biosystems) with forward primer or reverse primer. 
For identification, sequences were compared with 
sequences of known bacteria listed in official 
databases using the BLAST program available at 
the National Center for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov/BLAST/).
Viral protocol
   We used a LAMP assay for the detection of HSV-
1,2, VZV, CMV, EBV and HHV-6,7. If a LAMP 
assay is positive, we performed a real-time PCR for 
these viruses.
DNA extraction protocol:
   A 400μl of EDTA-anticoagulated blood was used 
for the assay. The sample was stored at -80℃ until 
it was applied for DNA extraction.
   For DNA extraction, QIAamp DNA Blood Mini 
kit (QIAGEN, Basel Switzerland) was used under 
the instruction of the manufacture. DNA was stored 
at 4℃ until tested.
LAMP methods:
   Primers and reaction steps were referred to 
previous described methods for detection of HSV-
1,2, VZV, CMV, EBV and HHV-6,710-16).
Real-time PCR:
   Primers, probes and PCR protocol were referred to 
previous described methods for detection of HSV-
1,2, VZV, CMV, EBV and HHV-6,717-20).
Statistical analysis:
   For statistical analysis, Stat View 5.0® software 
(SAS Institute, Inc., Cary, NC, U.S.A.) was used.
The results were compared between the two groups 
using the Mann-Whitney U test. To examine 
the correlation among factors, Spearman’s rank 
correlation coefficient (non-parametric method) 
was used. The date were considered statistically 
significant if p-value was less than 0.05.
RESULTS
Population Characteristics
   A total of 76 patients with FNEs were admitted 
to the Departments of Pediatrics, the Department 
of Hematology, and the Department of Respiratory 
Medicine in Kawasaki Medical School Hospital 
during June 2012 to April 2013. Twenty two of 76 
FNEs revealed positive results by blood culture and/
or nucleic acid amplification tests. Characteristics 
and Laboratory data of 76 patients are listed in 
Table 1. Median age of patients was 38 years (range, 
1-72 years). Among 76 patients of FNEs, 62 patients 
Table 1. Characteristics of the patients with febrile neutropenia
Patient charactreristic Value
Median age (years)
Male (%)
38 (1 ～ 72)
8 (44)
No.(%) of patients with diagnosis 
     Acute Lymphoblastic Leukemia
     Acute Myeloid leukemia
     Non Hodgkin lymphoma
     NK/T cell Lymphoma
     Hepatoblastoma
     Lung cancer
4 (22)
3 (17)
5 (2)
1 (6)
1 (6)
4 (22)
Use of central  venous catheter (%)
Median temperature (℃)
Median time of fever prior to admission (min)
14 (78)
38.2 (38.0-38.5)
45 (5 ～ 105)
WBC (/μl)
Neutro (/μl)
CRP on set (mg/dl)
CRP max (mg/dl)
439 (10 ～ 4,000)
82 (0 ～ 861)
4.35 (0.35 ～ 29.66)
10.78 (0.88 ～ 31.40)
Fever period (days) 4.5 (1 ～ 11)
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Table 2. Bacterial culture results and molecular diagnosis results of patients with febrile neutropenia episodes in this study
NHL : non-Hodgikin’s lymphoma, HB : hepatoblastoma, AML : acute myeloid leukemia, ALL : acute lymphoblastic leukemia
Sample
Blood culture
Real-time PCR and PCR, sequence, and identiﬁcation
Patients Age diagnosis SQ mean BLAST Bit score, identities
7
11
12
14
18
20
21
22
23
24
25
26
27
35
36
37
38
39
40
46
48
63
66y
1y7m
1y7m
85y
43y
7y6m
11y7m
16y8m
11y7m
7y6m
3y8m
16y8m
16y8m
7y6m
5y10m
16y8m
16y8m
11y7m
11y7m
7y6m
16y8m
13y1m
NHL
HB
HB
NHL
NK/T cell 
Lymphoma
AML
ALL
AML
ALL
AML
ALL
AML
AML
AML
ALL
AML
AML
ALL
ALL
AML
AML
NHL
Negative
Streptococcus mitis
Negative
Negative
Klebsiella pneumoniae
Neisseria sp
Negative
Negative
Streptococcus mitis
Streptococcus mitis
Negative
Negative
Negative
Streptococcus mitis
Negative
Streptococcus mitis
Streptococcus mitis
Negative
Negative
Streptococcus mitis
Negative
Negative
24.24
37.39
-
0.71
1.20 × 105
-
2.11
-
57.91
48.38
-
-
7.48
-
0.68
5.80
3.21
-
3.91
3.15
5.61
-
Enterococcus faecium
Streptococcus mitis
Streptococcus mitis
Acinetobacter junii
Klebsiella sp
Negative
Acinetobacter sp
Bacillus sp
Streptococcus mitis
Streptococcus mitis
Enterobacter sp
Enterobacter sp
Enterobacter sp
Negative
Streptococcus gordonii
Streptococcus mitis
Streptococcus mitis
Acinetobacter sp
Acinetobacter sp
Negative
E. Coli
Staphylococcus epidermidis
1,356, 99%
1,352, 99%
346, 91%
612, 84%
1,308, 98%
-
412, 73%
503, 84%
1,327, 99%
1,328, 99%
1,040, 96%
1,325, 98%
1,188, 97%
-
333, 79%
1,061, 95%
355, 93%
191, 89%
1,055, 94%
-
309, 77%
619, 91%
NHL : non-Hodgikin’s lymphoma, HB : hepatoblastoma, AML : acute myeloid leukemia, ALL : acute lymphoblastic leukemia
Table 3 . The correlation between Blood culture and a real-time 
PCR assay
Blood culture
positive
Blood culture
negative total
Real-time PCR
positive 6 13 19
Real-time PCR
negative 3 54 57
total 9 67 76
with FNEs were admitted to the Department of 
Pediatrics, 10 patients with FNEs to the Department 
of Hematology and 4 patients with FNEs to the 
Department of Respiratory Medicine. Seventy 
one out of 76 patients with FNEs (93.4%) had 
hematologic malignancies.
   Mean WBC count and neutrophil count were 434/
μl (range, 10-4,000) and 82/μl (range, 0-861). The 
mean duration from onset of FN to defervescing in 
normal temperature was 4.5 days (range, 1～11).
Comparison of the rate of detection between blood 
culture and nucleic acid amplication test:
   All patients were performed blood culture once 
or twice on the first day of the febrile episodes, 
and a positive result was obtained in 9 FNEs, such 
as Streptococcus mitis, Klebsiella pneumoniae, 
Streptococcus mitis, Neiseria sp.
   On the other hand, the real-time PCR assay was 
positive in 19 FNEs.
   The real-time PCR assay detected Enterococcus 
faecium, Streptococcus mitis, Acinetobacter 
junii, Acinetobacter sp, Klebsiella sp, Bacillus 
sp, Enterobacter sp, Streptococcus gordoni and 
Staphylococcus epidermidis (Table 2).
   In 60 of 76 (79%) FNEs, blood culture and 
the real-time PCR assay gave the same results, 
regardless of positive and negative results.
   Of these samples, bacteria were identified in 19 
of 76 FNEs (25.0%) by real-time PCR and in only 
9 of 76 (11.8%) by blood culture. In 6 of 9 blood 
culture-positive samples, the real-time PCR assay 
detected the same type of bacteria (No.11, 18, 23, 
24, 37, 38).
   Comparing with blood culture, the real-time PCR 
assay for bacteria had a sensitivity, specifity, and 
positive and negative predictive value of 67%, 81%, 
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32% and 95%, respectively (Table 3).
   In this study, fungi were not detected in 76 FNEs 
by blood culture and the real-time PCR assay. β-D 
gulcan was negative in all cases.
Comparison of the detection speed between blood 
culture and real-time PCR:
   It took an average of 9 hours 59 minutes for blood 
culture to become positive in this study. It took 
another 24 hours more so that causative bacteria 
were identified. 
   It took an average of 4 hours for obtaining positive 
results by the real-time PCR assay and another 12 
hours for the sequence results (data not shown).
Molecular Results and Clinical course:
   The number of bacteria DNA copy and serum 
CRP titer of patients with FNE did not correlated 
well (Fig.2).
   As for No.14 patient, Acinetobacter junii was 
detected from blood, but the quantity of bacteria 
DNA copy was as few as 0.71 copy/μl and very 
small amount. However, his serum CRP titer was 
high as 21.44mg/dl. He died because of encephalitis 
two days after the FN onset. On the contrary, No. 
18 patint was detected Klebsiella sp from blood, 
and the quantity of bacteria was as many as 1.20×
105 copy/μl. However, her serum CRP titer was 
not so high as 6.17 mg/dl. She was started with 
biapenem for FN. But she did not respond well, 
then she was switched from biapenem to doripenem 
and vancomycin on Day 4. In consideration of a 
catheter-related infection, her central-vein catheter 
was removed on Day 5. She defervesced on Day 6.
   The antibiotic therapy was not given to 74 of 76 
FNEs before the FN onset, so FN developed in only 
two patients (No.7, No.12) during the preventive 
antibiotic therapy. No.7 patient was collected blood 
culture during the tazobactam/piperacillin treatment. 
The result of blood culture was negative, however 
Enterococcus faecium was detected by the real-time 
PCR assay. Similarly, No.12 patient was collected 
blood culture during doripenem and amikacin 
treatment. The blood culture was negative, however 
Streptococcus mitis was detected by the real-time 
PCR assay.
   Nine patients with FNEs who were detected 
Enterococcus faecium, Acinetobacter junii and sp, 
CRP (mg/dl) 
SQ mean 
(copy/μl)  
Fig.2 
r=0.26 
 
P=0.12 
Fig. 2.　The correlation between a number of bacterial DNA copy and serum CRP titer.
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Enterobacter sp , E.coli and Bacillus sp. by the real-
time PCR assay presented acute diarrhea, but blood 
culture was negative in all cases (No.7, 21, 22, 25, 
26, 27, 39, 40).
   On the other hand, as to 9 patients with FNEs who 
were detected Streptococcus mitis, Streptococcus 
gordonii  and Neisseria  associated episodes 
regardless of blood culture and the real-time PCR 
assay, oral mucositis developed in all these 9 
cases (No.11, 12, 20, 23, 24, 35, 36, 37, 38). Two 
out of 9 patients with FNEs who were detected 
Streptococcus mitis were complicated with pleuritis 
(No.37, 38). One patient with FNE who was 
detected Klebsiella pneumoniae developed catheter-
related infection (No.18).
   As for No. 63, Staphylococcus epidermidis was 
detected, but there was no other symptom than 
fever. 
   In 11 cases with the real-time PCR positive results, 
FN was successfully treated by empirical therapy 
(Table 4). However 11 cases of blood culture or 
real-time PCR positive results, fever continued 
after the administration of empirical therapy more 
than 48 hours, they were quickly switched to other 
antimicrobial therapy, then they were successfully 
treated with the following antibiotic treatment.
A LAMP assay and a real-time PCR assay for the 
detection of human herpes virus type1 to 7
   Viruses were detected in 6 of 76 FNEs (7.9%) by 
LAMP methods (Table 5).
   EBV was detected with No.15 patient and No.18 
Table 4. Clinical courses of patients with febrile neutropenia episodes
Patients Blood culture Real-time PCR and PCR,sequence
CRPmax
(mg/dl) antibiotics Clinical course
7
11
12
14
18
20
21
22
23
24
25
26
27
35
36
37
38
39
40
46
48
63
Negative
Streptococcus mitis
Negative
Negative
Klebsiella pneumoniae
Neisseria sp
Negative
Negative
Streptococcus mitis
Streptococcus mitis
Negative
Negative
Negative
Streptococcus mitis
Negative
Streptococcus mitis
Streptococcus mitis
Negative
Negative
Streptococcus mitis
Negative
Negative
Enterococcus faecium
Streptococcus mitis
Streptococcus mitis
Acinetobacter junii
Klebsiella sp
Negative
Acinetobacter sp
Bacillus sp
Streptococcus mitis
Streptococcus mitis
Enterobacter sp
Enterobacter sp
Enterobacter sp
Negative
Streptococcus gordonii
Streptococcus mitis
Streptococcus mitis
Acinetobacter sp
Acinetobacter sp
Negative
E. Coli
Staphylococcus epidermidis
29.66
17.52
17.52
21.44
6.17
3.41
16.47
5.88
31.40
20.85
3.84
2.06
2.06
15.54
6.63
11.25
11.25
8.12
8.12
17.50
3.62
3.62
MEPM+VCM
CZOP+AMK
DRPM+AMK
TAZ/PIPC+AMK
BIPM
CFPM+AMK
CFPM+AMK
CFPM+AMK
CFPM+AMK
CFPM+AMK
CZOP+AMK
CFPM+AMK
CFPM+AMK
CZOP+AMK
CZOP+AMK
CFPM+AMK
CFPM+AMK
CFPM+AMK
CFPM+AMK
CZOP+AMK
CFPM+AMK
CFPM+AMK
Improved with ET
Registant to ET
Improved with ET
Resistant to ET
Resistant to ET
Resistant to ET
Improved with ET
Resistant to ET
Resistant to ET
Resistant to ET
Improved with ET
Improved with ET
Improved with ET
Resistant to ET
Improved with ET
Resistant to ET
Registant to ET
Improved with ET
Improved with ET
Resistant to ET
Improved with ET
Improved with ET
MEPM : meropenem, VCM : vancomycin, CZOP : cefozopran, AMK : amikacin, DRPM : doripenem, TAZ/PIPC : tazobactam/
piperacillin, BIPM : biapenem, CFPM : cefepime, ET : empirical therapy.
Table 5. Results of viral molecular diagnosis results in patients with FNEs
sample
LAMP Real-time PCR
Number Age diagnosis
15
18
31
32
61
62
43y
43y
11y7m
11y7m
12y1m
12y1m
NK/T cell Lymphoma
NK/T cell Lymphoma
ALL
ALL
ALL
ALL
EBV
EBV
HHV6
HHV6
HHV6
HHV6
EBV 20.2
EBV 161.0
HHV6 859.0
HHV6 530.0
HHV6 2.6 × 104
HHV6 2.7 × 104
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patient. The quantity of EBV of the samples was 
20.2 copy/μl in No.15 patient, and 161copy/μl 
in No.18 patient by the real-time PCR assay, 
respectively. The samples were collected in No.15 
patient and No.18 patient from the same patient 
whose clinical diagnosis was NK/T cell Lymphoma 
in different time, and No.18 patient accompanied 
a catheter-related infection caused by Klebsiella 
pneumoniae.
   HHV6 was detected with No.31, 32, 61 and 62. 
These 4 cases were collected from the same patients. 
No.31 and No.32 were collected in the same time. 
Similarly, No.61 and No.62 were sampled in same 
time. The patient was a 11-years-old 7 months 
girl with acute lymphoblastic leukemia (ALL), at 
the nadir period of consolidation chemotherapy 
(No.31, 32) and maintenance chemotherapy (No.61, 
62). She was extra high risk ALL, but she did not 
undergo hematopoietic stem cell transplantation and 
was treated with only chemotherapy.
DISCUSSION
   Blood culture currently remains the gold standard 
in microbiological diagnosis of FN, although it 
becomes positive 8-36 hours after sampling21). It 
took an average of 9 hours 59 minutes in our study. 
Furthermore, it took another 24 hours more so 
that causative bacteria and fungi were identified. 
We used empirical antibiotics in consideration of 
causative bacteria or fungi predicted for FNEs. 
However it takes much time for the identification 
of causative bacteria by blood culture, so we cannot 
give appropriate and specific antimicrobial therapy 
quickly. In our study, it took an average of 1 hour 
30 minutes for a real-time PCR assay and another 
average of 6 hours 30 minutes for the sequence. 
The real-time PCR was able to identify causative 
bacteria and fungi more quickly than blood culture. 
   The real-time PCR assay for detection of 
causative microbes has been proving to be sensitive 
and specific with the additional advantage of rapid 
results. However general use of a real-time PCR 
assay in clinical practice remains limited due to the 
lack of standardization and it’s high cost22). Real-
time PCR techniques have a general limitation 
in being too sensitive. A broad-range PCR assay 
is more vulnerable due to contamination than a 
species-specific PCR assay3).  Contamination from 
environment, labwares or enzymes sometimes may 
happen to occur. There was no cut-off threshold (Ct) 
-value to distinguish real infections from baseline 
level of contamination DNA in negative sample2).
   We postulated that a copy number helped the 
determination of real clinical infection from 
contamination. However we could not find a good 
correlation between bacterial copy number and 
serum CRP titer (Fig.2). Rastogi R et al. reported 
many organisms have a single rRNA operon and 
the actual number is known to vary between 1 and 
1522,23). Because various species of bacteria were 
detected in this study, it might be hard to conclude a 
correlation between the number of copy and disease 
severity. In an adult population, Schabereiter-
Gurtner CS et al.2) reported an increase in positivity 
from 16.9% (23/136) with blood culture to 24.3% 
(33/136) with a broad-range real-time PCR assay. 
In children, Nakamura A et al.1) detected bacteria 
in 3 cases (13%) by blood culture and in 11 cases 
(48%) by PCR in 23 FNEs, Santolaya ME et al.22) 
increased positivity from 16.3% (29/177) by blood 
culture to 20% (36/177) by a real-time PCR assay in 
FN children with cancer.
   The present study showed that we significantly 
improved the detection rate from 11.8% by blood 
culture to 25.0% by a real-time PCR assay in 
patients with FNEs. 
   On the other hand, a sensitivity of the real-time 
PCR assay among blood culture positive cases was 
only 67%. In 3 blood culture-positive cases (No.20, 
35, 46), the real-time PCR assay could not detect 
any bacteria. We tried the detection of bacteria for 
9Teranishi H, et al. : Detection of microbes by a Real-time PCR assay in Patients with FN
these 3 cases by increase of DNA quantity in the 
template, however any bacteria were not detected. 
It may be considered that quantity of bacteria was 
lower than the detection limit of the real-time PCR 
assay in these cases. Santolaya et al also reported 
the low sensitivity of the PCR assay as 56%, which 
is similar to the present study.
   Lilienfeld-Toal M et al.24) reported an increase 
in positivity from 3% with blood culture to 15% 
with a multiplex real-time PCR assay in 119 FNEs 
episodes of adult patients during antibiotic therapy. 
In this study, two patients (No.7, 12) were detected 
causative bacteria during the preventive antibiotic 
therapy. It was thought that a real-time PCR assay 
was a useful and strong tool for the pathogen 
detection during antibiotic therapy.
   In this study, fungi were not detected in 76 
FNEs by blood culture and the real-time PCR 
assay, although several reports have shown a real-
time PCR assay was useful for early detection of 
fungi6-9). However fungi are rarely detected, because 
antifungal therapy is often given preventively. 
No detection of fungi in this study may be due 
to antifungal prophylaxis with micafungin or 
fluconazole in all cases during ANC of <500 cells/
mm3.
   In this study, viruses were detected in 6 of 76 FNE 
(7.9%) by the LAMP methods and real-time PCR. 
EBV was detected with No.15 and 18 in the same 
patient, but NK/T cell lymphoma was known to be 
related to EBV infection. EBV detected in No.15 
and 18 might be due to primary disease and not be 
due to FNEs. HHV6 was detected in No.31, 32, 61 
and 62 from the same ALL girl, because she was 
at extra high risk group of ALL and, the intensity 
of chemotherapy was very high. Therefore, her 
immunosuppression was very strong, and it may be 
considered that she was infected with a reactivation 
of HHV6. In this study, the specimens from patients 
undergoing hematopoietic stem cell transplantation 
(HSCT) was only two. If the specimens from HSCT 
patients increase, the rate of detection of virus may 
rise. Because cell-mediated immune deficiency 
occur by HSCT, T cell depletion increases the risk 
of viral reactivation and virus-related disease25).
   We conclude a real-time PCR assay could give its 
higher detection rate, and shorter turnaround time, 
and the smaller volume of blood sample than blood 
culture. A real-time PCR assay along with blood 
culture improve microbiological documentation in 
FNEs. We may choose early optimal antibiotics to 
patients with FNEs by a real-time PCR assay.
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